Xavier Bertrand mainly investigates Microbiology, Pseudomonas aeruginosa, Intensive care, Antibiotic resistance and Antimicrobial. The various areas that Xavier Bertrand examines in his Microbiology study include Pulsed-field gel electrophoresis, Gene, Escherichia coli, Multilocus sequence typing and Ceftazidime. Many of his research projects under Pseudomonas aeruginosa are closely connected to Effluent with Effluent, tying the diverse disciplines of science together.
Xavier Bertrand combines subjects such as Colonisation, Colonization, Emergency medicine, Intensive care unit and Pediatrics with his study of Intensive care. Xavier Bertrand interconnects Internal medicine and Antibiotics in the investigation of issues within Antimicrobial. His research in Internal medicine intersects with topics in Surgery and Intensive care medicine.
Xavier Bertrand focuses on Microbiology, Pseudomonas aeruginosa, Antibiotics, Internal medicine and Staphylococcus aureus. His study in Microbiology is interdisciplinary in nature, drawing from both Multilocus sequence typing, Pulsed-field gel electrophoresis and Escherichia coli. His research investigates the link between Pseudomonas aeruginosa and topics such as Intensive care that cross with problems in Intensive care unit.
His Antibiotics research incorporates themes from Medical prescription, Antimicrobial and Vancomycin. His work on Incidence, Confidence interval and Prospective cohort study as part of his general Internal medicine study is frequently connected to Carriage, thereby bridging the divide between different branches of science. His studies examine the connections between Antibiotic resistance and genetics, as well as such issues in Ceftazidime, with regards to Cefotaxime.
Xavier Bertrand mostly deals with Microbiology, Internal medicine, Pseudomonas aeruginosa, Antibiotic resistance and Escherichia coli. His studies deal with areas such as Methicillin Susceptible Staphylococcus Aureus, Endocarditis, Proteus mirabilis, Enterobacteriaceae and Multilocus sequence typing as well as Microbiology. His Intensive care unit, Incidence, Multivariate analysis and Confidence interval study, which is part of a larger body of work in Internal medicine, is frequently linked to Carriage, bridging the gap between disciplines.
His work carried out in the field of Pseudomonas aeruginosa brings together such families of science as Pathogen, Typing, Genomic island and Pulsed-field gel electrophoresis. His Antibiotic resistance research is under the purview of Antibiotics. His biological study spans a wide range of topics, including Drug resistance, Emergency medicine and Environmental health.
Microbiology, Pseudomonas aeruginosa, Antibiotic resistance, Klebsiella pneumoniae and Multilocus sequence typing are his primary areas of study. His research on Microbiology focuses in particular on Typing. His work on Acinetobacter baumannii as part of general Pseudomonas aeruginosa research is frequently linked to Multidrug tolerance, bridging the gap between disciplines.
Antibiotic resistance is a subfield of Antibiotics that Xavier Bertrand studies. His Klebsiella pneumoniae research is multidisciplinary, incorporating perspectives in Contamination, Ecosystem and Bacteria. His studies in Multilocus sequence typing integrate themes in fields like Multiple drug resistance and Pulsed-field gel electrophoresis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Escherichia coli ST131, an Intriguing Clonal Group
Marie-Hélène Nicolas-Chanoine;Xavier Bertrand;Jean-Yves Madec.
Clinical Microbiology Reviews (2014)
Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units.
X Bertrand;M Thouverez;D Talon;A Boillot.
Intensive Care Medicine (2001)
What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems.
D Hocquet;Allison Muller;X Bertrand.
Journal of Hospital Infection (2016)
10-Fold increase (2006–11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre
Marie Hélène Nicolas-chanoine;Marie Hélène Nicolas-chanoine;Coraline Gruson;Suzanne Bialek-Davenet;Suzanne Bialek-Davenet;Xavier Bertrand.
Journal of Antimicrobial Chemotherapy (2013)
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study
Andréw James Stewardson;Arthur Allignol;Jan Beyersmann;Nicholas Graves.
Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009
Peter Zarb;Brice Amadeo;Arno Muller;Nico Drapier.
Journal of Antimicrobial Chemotherapy (2011)
Control of the duration of urinary catheterization: impact on catheter-associated urinary tract infection
J. Crouzet;X. Bertrand;A.G. Venier;M. Badoz.
Journal of Hospital Infection (2007)
Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum β-Lactamase–Producing Escherichia coli Into the Environment
Caroline Bréchet;Julie Plantin;Marlène Sauget;Michelle Thouverez.
Clinical Infectious Diseases (2014)
Can MALDI-TOF Mass Spectrometry Reasonably Type Bacteria?
Marlène Sauget;Benoît Valot;Xavier Bertrand;Didier Hocquet.
Trends in Microbiology (2017)
Relationship between Spread of Methicillin-Resistant Staphylococcus aureus and Antimicrobial Use in a French University Hospital
Arno A. Muller;Frédéric Mauny;Maud Bertin;Christian Cornette.
Clinical Infectious Diseases (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: